You are here

Article metrics

Article menu
Basic tumor immunology
Original research
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma

 

Online download statistics by month:

Online download statistics by month: February 2023 to February 2026

AbstractFullPdf
Feb 2023727412
Mar 2023617626158
Apr 202323623727
May 202315816238
Jun 202315615626
Jul 202311911925
Aug 202317717825
Sep 202313713821
Oct 20239610038
Nov 202313413528
Dec 202310810918
Jan 202411911929
Feb 2024707033
Mar 202412112365
Apr 2024949440
May 2024889032
Jun 202411211326
Jul 2024737639
Aug 2024515223
Sep 2024818193
Oct 2024979951
Nov 2024777825
Dec 2024838528
Jan 2025686929
Feb 202520120140
Mar 202512512565
Apr 202515916065
May 2025919241
Jun 2025676941
Jul 2025110
Aug 2025110
Feb 2026100
Total379038321181